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The target sites of soluble myosin heavy chain kinases partially purified from growth phase or aggregation competent cells of Dictyostefium discoi- 
deum were identified by the usiz of normal and mutated fragments of the myosin heavy chain. The kinases from both developmental stages phospho- 
rylated two previously established threonine residues, as well as an additional one. The newly identified site is located within the putative core 
region of the coiled-coil formed by the myosin tail. A lysine following the phosphorylated threonine residue is the only common feature of the 
sequences around these sites. The kinases, which specifically phosphorylate threonine residues in wild-type myosin, did accept serine if it was in 
the right structural context. 
Cell motility; Chemotaxis; Rictyostekm discoideum; Myosin phosphorylation 
1. INTRODUCTION 
Phosphorylation of myosin II, the double-headed 
myosin of Dictyostelium discoideum, is regulated upon 
stimulation of cells with the chemoattractant CAMP 
[l-3]. Phosphorylation inhibits thick filament forma- 
tion and reduces the actin-activated Mg2 + -ATPase ac- 
tivity of the myosin [4,5]. These effects suggest an in- 
volvement of myosin phosphorylation in the control of 
cell motility during the chemotactic response. In 
mutants lacking myosin II the average speed of cell 
movement and precision of the chemotactic response 
are reduced [6,7]. The most dramatic defect observed in 
these mutants is the inability of the cells to divide 
properly [8,9]. This finding shows that myosin II is re- 
quired for cytokinesis and raises the question whether 
its phosphorylation is also involved in controlling this 
important function. 
tant [3]. The biological question behind the studies on 
myosin phosphorylation in Dictyostelium is how 
phosphorylation affects the functions of myosin in 
vivo. Because of the multiple phosphorylation sites and 
the site specific differences in the regulation of 
phosphorylation, it is necessary to investigate the conse- 
quences of phosphorylation at specific sites separately 
from phosphorylation at other sites. In order to do that, 
we have identified threonine residues on the myosin 
heavy chains which are phosphorylated by a certain 
class of kinases and have replaced these threonine 
residues by either serine or alanine residues. In the pre- 
sent paper we report on the results of in vitro 
phosphorylation obtained with the mutated poiypep- 
tides. 
Upon stimulation of cells with CAMP, changes of 
both myosin heavy and light chain phosphorylation 
have been observed [2]. On the light chains specifically 
serine residues are phosphorylated. On the heavy chains 
threonine as well as serine residues are phosphorylated, 
the phosphorylation of threonine residues showing a 
stronger increase after stimulation by the chemoattrac- 
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Soluble kinases that specifically phosphorylate 
threonine residues of the MHC have been purified from 
growth phase (kinase,,) and aggregation competent 
(kinase,) cells [5,10]. Previous results obtained with 
kinase, indicated that the phosphorylated sites are 
restricted to a tail region of the myosin close to the C- 
terminus of the heavy chain [ll]. By comparing the 
lengths of phosphorylated and non-phosphorylated 
MHC fragments in partial proteolytic digests and by the 
analysis of phosphopeptide patterns, it was predicted 
that at least two phosphorylation sites are located in a 
stretch of amino acids containing four threonine 
residues, and that the residues are separated by cleavage 
sites for trypsin and chymotrypsin [l 11. Kinase,, was 
shown by heavy chain peptide sequencing to 
phosphorylate one of the four residues, T-1833, and in 
addition a distant site, T-2029 [ 121. The region contain- 
ing all established and putative phosphorylation sites is 
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included in a cDNA-encoded, bacterially expressed 
fragment of the MHC which can be used as a substrate 
of MHC kinases from D. discoideum [13,14]. We have 
engineered this fragment by site-directed mutagenesis 
for three reasons: (i) in order to establish that the 
kinases from both developmental stages have the same 
site specificity, (ii) to test whether these kinases accept 
serine instead of threonine when the serine is in the posi- 
tion of a phosphorylation site, and (iii) in order to 
eliminate all the sites phosphorylated by these kinases. 
kDa portion of MHC were purified from transformed E.coli C600 
cells as described [14]. 
2.2. Phosphorylation of myosin and fusion proteins; identification 
of the phosphorylated amino acids 
For phosphorylation 20 gg of myosin or 50 cg of the fusion proteins 
were supplemented with 1 mM EGTA, 5 mM MgC12 and 0.2 mM 
[Y-~‘P]ATP (100 kBq per assay) in 50~1 of Tris-HCI, pH 7.5, contain- 
ing 30% sucrose, 1 mM DTT, and 0.02% NaNs. After incubation for 
15 min at 30°C with either kinase,, or kinase,, the samples were boil- 
ed in SDS-sample buffer and subjected to SDS-polyacrylamide gel 
electrophoresis n 10% gels. Protein bands were excised from the gels 
and digested with trypsin and chymotrypsin [15]. The peptides were 
hydrolyzed and subjected to two-dimensional electrophoresis as 
described by Hunter and Sefton [16]. Phosphorylated amino acids 
were identified by autoradiography and staining of coelectrophores- 
ed, authentic amino acids with ninhydrin. 
2. MATERIALS AND METHODS 
2.1. Purification of proteins 
D. discoideum yosin II was prepared from aggregation competent 
AX2 cells as described by Maruta et al. [5]. MHC kinase from growth 
phase cells was prepared essentially according to C&e and Bukiejko 
[lo]. However, instead of a Bio Gel A-1.5 m column a Sephacryl 
S-300 column (2.5 x 115 cm) from Pharmacia was used and the final 
aminohexyl-Sepharose 4B column was omitted. The MHC kinase 
from aggregation competent cells was partially purified following 
procedure II of Maruta et al. [5], omitting the final Blue Sepharose 
and Sephadex G-100 steps. Wild-type and mutated 74 kDa fusion pro- 
teins containing 11 kDa of an MS-2 polymerase fragment and a 58 
2.3. Site-directed mutagenesis 
A 1.5 kb EcoRI fragment of cDNA encoding amino acids 1534 to 
2032 of D. discoideum MHC was cloned into the EcoRI site of 
plasmids pMa/cS-8 provided to us by H.-J. Fritz [17]. Site-directed 
mutagenesis was performed using the gapped duplex DNA method of 
Stanssens et al. [17] with oligonucleotides synthesized on an Applied 
Biosystems DNA synthesizer. Partial sequencing using the dideox- 
ynucleotide chain termination method [18] confirmed the mutations. 
For expression of the fusion proteins the mutated 1.5 kb fragments 
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Fig. 1. (Top) Map of cDNA for the D. discoideum MHC showing the position of a 1.5 kb EcoRI fragment hat encodes the protein fragment used 
as a substrate for MHC kinases. (Bottom) Location of mutated threonine residues on the fragment, and diagram of constructs assayed as kinase 
substrates. The mutated amino acids are numbered according to the MHC sequence of Warrick et al. [19]. The three residues identified as 
phosphorylation sites are boxed. 
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WT 
Fig. 2. fdentifiition of the p~os~~~~rn~o acids of wild-type (WT) 
and mutated MHC Fragments A-F as diagrammed in Fig. 1. The 
fragments were either phosphorylated with kinases, (left column) or 
kinase, (right column). Broken lines indicate positions of authentic 
carrier phosphoamino acids. 
were cloned into the EcoRf site of pEx33B as described for the wifd- 
type fusion protein [14]. 
3. RESULTS 
MHC kinase,, was partially purified from growth 
phase cells of D. ~~~~o~~~~ essentially as described by 
C&e and Bukiejko [IO] and MHC kinaseallB from ag- 
gregation competent cells, following a procedure 
similar to that of Maruta et al. [5]. In accord with the 
published results, the kineses of both preparations 
phosphor~lated specifically threonine residues on the 
heavy chains of intact D. d~~~~de~~ myosin. 
As substrates for the kinases, the normal and 
mutated MHC fragments hown in Fig. 1 were used. In 
a first set of mutageneses four threonine residues be- 
tween positions 1823 and 1837 were replaced by serine 
(Fig. 1, mutants A-F). After ~hosphor~lation of the 
mutated MHC fragments by kinasq, or kinase,, the 
phosphoamino acids were analyzed (Fig. 2) When only 
the single residue T-1823 was changed, a small but 
significant amount of phosphoserine was found (Fig. 2, 
mutant A). If the cluster of residues 1833, 1835, and 
Fig. 3. Coomassie-Blue polyacrylamide gels (A) and autoradiograms 
(B) showing normal and mutated MHC fragments phosphorylated 
with either kinases, (Left panel) or kinasp, (righi panel). Lanes I: 
Controls, containing kinase preparations without added substrate 
protein. Lanes 2: With wild-type MHC fragment added. Lanes 3: 
With the mutated fragment H of Fig. 1 added. Lanes 4: With frag- 
ment G added in which five threonine residues are replaced by 
alanine. 
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1837 was mutated, a large amount of phosphoserine 
was obtained in addition to phosphothreonine (Fig. 2, 
mutant B), indicating at least one phosphorylation site 
within this cluster (Fig. 1). This site was identified by 
replacing the three threonine residues in the cluster 
separately. Phosphoserine was produced only when 
T-1833 was mutated (Fig. 2, mutants C-E). 
Production of phosphothreonine after mutation of 
all four threonine residues into serine (Fig. 2, mutant F) 
indicated the presence of a third target site for both 
kinase,, and kinase, which is located in another 
region of the cloned MHC fragment. Since it appeared 
likely that the additional site is T-2029, which was 
shown to be phosphorylated in intact myosin by 
kinase,, [12], this threonine residue was replaced in ad- 
dition to the four other ones by alanine (Fig. 1, mutant 
G). The resulting fragment was not detectably 
phosphorylated with either kinase (Fig. 3, lanes 4). 
Similarly, no phosphorylation was obtained with a 
MHC fragment in which only at the positions 1823, 
1833 and 2029 the threonine residues were replaced by 
alanine (Fig. 1, mutant H). Mutation of T-1833 and 
T-2029 to alanine was employed in order to confirm the 
newly identified phosphorylation site at position 1823 
A 
B 
(Fig. 1, mutant I). Substantial phosphorylation observ- 
ed after elimination of these two sites (Fig. 3, lanes 3) 
established that in wild-type myosin three threonine 
residues are phosphorylatable by the kinases used. 
4. DISCUSSION 
The soluble MHC kinases used in this study showed 
the same specificity, although previous reports in- 
dicating different regulatory properties of the MHC 
kinases from growth phase and aggregation competent 
cells inferred that these enzymes might not be the same 
[S] . Because kinase,, and kinase,, phosphorylated the 
same threonine residues on the heavy chains, the results 
obtained with both kinase preparations will be discuss- 
ed together. 
In vivo and in vitro phosphorylation studies have 
shown that D. discoideum cells contain kinases that 
phosphorylate serine residues on light and heavy chains 
[3]. The kinases used in the present study phosphorylate 
only threonine residues of the heavy chains [5,10]. The 
finding that replacement of phosphorylatable threonine 
residues by serine does not abolish phosphorylation 
(Fig. 2), shows that these kinases do not require 
196aa 
I 
phosphorylation. 
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Fig. 4. Diagram of the location of threonine-1823 within the o-helix (A) and possible effect of its phosphorylation on myosin polymerization (B). 
(A) Seven amino acid residues representing two turns of the cu-helices of the two heavy chains that comprise the myosin tail are illustrated in a 
top view. Residues indicated by dark circles make up the hydrophobic core of the coiled coil [ 191. T-1823 in its phosphorylated state might decrease 
the hydrophobic interaction between the two subunits. (B) Model of the assembly of two myosin molecules by charge-charge interaction and its 
suppression by phosphorylation. T-1823 is situated within a positive charged stretch of the MHC sequence which is flanked by two negatively charg- 
ed stretches. Charge-charge interaction between the positive and negative regions would produce a stagger interval of 14.3 nm, as suggested by 
H.M. Warrick (personel communication), and phosphorylation of T-1823 might affect the intermolecular bonds. 
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threonine as a target site. We conclude that the site 
specificity of phosphorylation is either determined by 
the sequence context or by restrictions due to the con- 
formation of the region into which the phosphorylat- 
able residues are embedded. 
By systematically mutating putative phosphorylation 
sites into serine residues we have found a third 
phosphorylatable residue, T-1823, at the myosin heavy 
chain. The phosphorylatable residues T-1823, T-1833, 
and T-2029 have a lysine at their C-terminal side as the 
only obvious sequence context in common. Since there 
are other T-K pairs in the cloned MHC fragment used 
as a kinase substrate where no phosphorylation was 
detected, the lysines might be necessary but are not suf- 
ficient for phosphorylation to occur. 
The tail of the MHC contains a 7-residue repeat, 
characteristic of cY-helical coiled-coil proteins in which 
the first and fourth amino acids are highly hydrophobic 
[19]. This pattern allows the formation of an internal 
hydrophobic core of the coil. Whereas T-1833 and 
T-2029 lie adjacent to but not within the predicted 
hydrophobic core [ 121, T- 1823 is located at a core posi- 
tion (Fig. 4A). Therefore, the hydrophilicity produced 
by its phosphorylation may cause a strong disturbance 
of the coiled-coil structure. Moreover, T-1823 lies 
within a stretch of amino acids where 11 out of 23 
residues are positively charged. This is the highest ac- 
cumulation of positive charges within the complete 
MHC tail sequence. This region of positively charged 
amino acids falls into the middle of two sequences of 
negatively charged amino acids which are 196 residues 
apart (Warrick, H.M., personal communication). The 
14.3 nm stagger of a myosin filament is known to cor- 
respond to one-half of 196 amino acids [19]. A possible 
mechanism of filament formation would be the charge- 
charge interaction of the positive stretch of amino acids 
with the negative stretch at another myosin molecule 
(Fig. 4B). Decrease of the net charge in the positive 
region by phosphorylation might contribute to the in- 
hibition of filament formation as has been observed as 
a consequence of MHC phosphorylation [4]. 
The results shown provide a basis for studies on the 
functional consequences of phosphorylation at defined 
threonine residues of the myosin tail. The three 
phosphorylation sites in question are shown to be 
phosphorylated independently of each other and they 
can be eliminated by site-directed mutagenesis separate- 
ly or in concert. Since it is unknown whether the MHC 
kinases discussed are the products of only one gene or 
of several genes, elimination of the phosphorylation 
sites might have a stronger effect on myosin functions 
in vivo than inactivation of one gene encoding a kinase. 
D. discoideum strains that lack certain phosphorylation 
sites can be produced by transformation of MHC null 
mutants [20] with vectors carrying mutated MHC 
coding regions. By recording cell motility and 
chemotaxis using image processing systems [7,21] it 
should be possible to quantitate effects of altered 
phosphorylation on cell behavior. 
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